4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-24-018671
Chief Scientific Officer sold 118,922 shares at $55.00 ($6,540,710)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reich Kristian Chief Scientific Officer | 2024-02-27 | Sale 10b5-1 | −29,491 | $55.00 | $1,622,005 | 2,957,483 | I |
| Reich Kristian Chief Scientific Officer | 2024-02-27 | Sale 10b5-1 | −29,431 | $55.00 | $1,618,705 | 70,071 | D |
| Reich Kristian Chief Scientific Officer | 2024-02-28 | Sale 10b5-1 | −31,910 | $55.00 | $1,755,050 | 2,925,573 | I |
| Reich Kristian Chief Scientific Officer | 2024-02-28 | Sale 10b5-1 | −28,090 | $55.00 | $1,544,950 | 41,981 | D |
| Open-market sales · 118,922 sh · avg $55.00 · $6,540,710 | |||||||
Loading xslF345X05/ownership.xml…